UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 433

Sortiert nach

T-cell immunity in the induction and maintenance of a tumour dormant state

Seminars in cancer biology, 2001-08, Vol.11 (4), p.285-295

Schirrmacher, V

2001

Link zum Volltext

Verfügbarkeit prüfen

Efficiency of adjuvant active specific immunization with Newcastle disease virus modified tumor cells in colorectal cancer patients following resection of liver metastases: results of a prospective randomized trial

Cancer Immunology, Immunotherapy, 2009-01, Vol.58 (1), p.61-69

2009

Link zum Volltext

Verfügbarkeit prüfen

Human tumor cell infection by Newcastle Disease Virus leads to upregulation of HLA and cell adhesion molecules and to induction of interferons, chemokines and finally apoptosis

International journal of oncology, 2002-07, Vol.21 (1), p.85

2002

Link zum Volltext

Verfügbarkeit prüfen

Harnessing oncolytic virus-mediated immunity

2015

Link zum Volltext

Verfügbarkeit prüfen

Recombinant Newcastle disease virus (NDV) with inserted gene coding for GM-CSF as a new vector for cancer immunogene therapy

Gene therapy, 2007-12, Vol.14 (23), p.1639-1649

2007

Link zum Volltext

Verfügbarkeit prüfen

Clinical trials of antitumor vaccination with an autologous tumor cell vaccine modified by virus infection: improvement of patient survival based on improved antitumor immune memory

Cancer Immunology, Immunotherapy, 2005-06, Vol.54 (6), p.587-598

Schirrmacher, Volker

2005

Link zum Volltext

Verfügbarkeit prüfen

Human tumor cell modification by virus infection : an efficient and safe way to produce cancer vaccine with pleiotropic immune stimulatory properties when using Newcastle disease virus

Gene therapy, 1999, Vol.6 (1), p.63-73

1999

Link zum Volltext

Verfügbarkeit prüfen

Astrophysical dust formation under the influence of temperature fluctuations : A general stochastic approach and its application to AGB winds

Astronomy and astrophysics (Berlin), 2008-12, Vol.491 (3), p.643-662

2008

Link zum Volltext

Verfügbarkeit prüfen

Antitumor effects of Newcastle Disease Virus in vivo: local versus systemic effects

International journal of oncology, 2001-05, Vol.18 (5), p.945

2001

Link zum Volltext

Verfügbarkeit prüfen

Tumour cell-dendritic cell fusion for cancer immunotherapy: comparison of therapeutic efficiency of polyethylen-glycol versus electro-fusion protocols

European journal of clinical investigation, 2002-03, Vol.32 (3), p.207-217

2002

Link zum Volltext

Verfügbarkeit prüfen

Dendritic cells pulsed with viral oncolysates potently stimulate autologous T cells from cancer patients

International journal of oncology, 2002-10, Vol.21 (4), p.685

2002

Link zum Volltext

Verfügbarkeit prüfen

Newcastle disease virus: a promising vector for viral therapy, immune therapy, and gene therapy of cancer

Methods in molecular biology (Clifton, N.J.), 2009, Vol.542, p.565

2009

Link zum Volltext

Verfügbarkeit prüfen

Second international conference on cancer vaccines/adjuvants/delivery for the next decade (CVADD): Heidelberg, Germany, 10–12 October 2007

Cancer Immunology, Immunotherapy, 2008-09, Vol.57 (9), p.1421-1427

2008

Link zum Volltext

Verfügbarkeit prüfen

Tumor-cell number and viability as quality and efficacy parameters of autologous virus-modified cancer vaccines in patients with breast or ovarian cancer

Journal of clinical oncology, 1997-04, Vol.15 (4), p.1354-1366

1997

Link zum Volltext

Verfügbarkeit prüfen

Polarization of human monocyte-derived dendritic cells to DC1 by in vitro stimulation with Newcastle Disease Virus

Journal of B.U. ON., 2009-09, Vol.14 Suppl 1, p.S111

2009

Link zum Volltext

Verfügbarkeit prüfen

Immunization with virus-modified tumor cells

Seminars in oncology, 1998-12, Vol.25 (6), p.677-696

1998

Link zum Volltext

Verfügbarkeit prüfen

Generation of dendritic cells from human bone marrow mononuclear cells: advantages for clinical application in comparison to peripheral blood monocyte derived cells

International journal of oncology, 2002-02, Vol.20 (2), p.247

2002

Link zum Volltext

Verfügbarkeit prüfen

Expression of RIG-I, IRF3, IFN-beta and IRF7 determines resistance or susceptibility of cells to infection by Newcastle Disease Virus

International journal of oncology, 2009-04, Vol.34 (4), p.971-982

2009

Link zum Volltext

Verfügbarkeit prüfen

Newcastle disease virus-infected intact autologous tumor cell vaccine for adjuvant active specific immunotherapy of resected colorectal carcinoma

Clinical cancer research, 1996-01, Vol.2 (1), p.21-28

1996

Link zum Volltext

Verfügbarkeit prüfen

Bone marrow as a priming site for T-cell responses to blood-borne antigen

Nature medicine, 2003-09, Vol.9 (9), p.1151-1157

2003

Link zum Volltext

Verfügbarkeit prüfen

In situ analysis of tumor-specific CTL effector and memory responses elicited by tumor vaccination

International journal of oncology, 1999-08, Vol.15 (2), p.217

Schirrmacher, V

1999

Link zum Volltext

Verfügbarkeit prüfen

Interaktionen zwischen Tumorantigen-reaktiven T-Zellen des Knochenmarks und Tumorzellen bei Patientinnen mit Mammakarzinom

Geburtshilfe und Frauenheilkunde, 2006-11, Vol.66 (11), p.1059-1065

2006

Link zum Volltext

Verfügbarkeit prüfen

Specific immune recognition of pancreatic carcinoma by patient-derived CD4 and CD8 T cells and its improvement by interferon-γ

International journal of oncology, 2006-06, Vol.28 (6), p.1419-1428

2006

Link zum Volltext

Verfügbarkeit prüfen

Tumor selective replication of Newcastle disease virus: Association with defects of tumor cells in antiviral defence

International journal of cancer, 2006-07, Vol.119 (2), p.328-338

2006

Link zum Volltext

Verfügbarkeit prüfen

Newcastle disease virus activates macrophages for anti-tumor activity

International journal of oncology, 2000-02, Vol.16 (2), p.363

2000

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 433

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(371)
Mit Volltextzugriff
(348)

Publikationsform

Sprache

Englisch
(411)
Deutsch
(27)
Japanisch
(19)

Erscheinungsjahr

n.n

Thema

Animals
(253)
Science & Technology
(231)
Life Sciences & Biomedicine
(220)
Mice
(214)
Biological And Medical Sciences
(143)
Oncology
(130)
Humans
(116)
Medical Sciences
(113)
Mice, Inbred Dba
(104)
Tumors
(72)
Cell Line
(60)
Immunology
(59)
Female
(57)
Neoplasm Metastasis
(56)
T-Lymphocytes - Immunology
(55)
Immunotherapy
(41)
Lymphoma - Immunology
(38)
Tumor Cells, Cultured
(38)
Fundamental And Applied Biological Sciences. Psychology
(36)
Mice, Inbred Balb C
(36)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

T-cell immunity in the induction and maintenance of a tumour dormant state

Efficiency of adjuvant active specific immunization with Newcastle disease virus modified tumor cells in colorectal cancer patients following resection of liver metastases: results of a prospective randomized trial

Human tumor cell infection by Newcastle Disease Virus leads to upregulation of HLA and cell adhesion molecules and to induction of interferons, chemokines and finally apoptosis

Harnessing oncolytic virus-mediated immunity

Recombinant Newcastle disease virus (NDV) with inserted gene coding for GM-CSF as a new vector for cancer immunogene therapy

Clinical trials of antitumor vaccination with an autologous tumor cell vaccine modified by virus infection: improvement of patient survival based on improved antitumor immune memory

Human tumor cell modification by virus infection : an efficient and safe way to produce cancer vaccine with pleiotropic immune stimulatory properties when using Newcastle disease virus

Astrophysical dust formation under the influence of temperature fluctuations : A general stochastic approach and its application to AGB winds

Antitumor effects of Newcastle Disease Virus in vivo: local versus systemic effects

Tumour cell-dendritic cell fusion for cancer immunotherapy: comparison of therapeutic efficiency of polyethylen-glycol versus electro-fusion protocols

Dendritic cells pulsed with viral oncolysates potently stimulate autologous T cells from cancer patients

Newcastle disease virus: a promising vector for viral therapy, immune therapy, and gene therapy of cancer

Second international conference on cancer vaccines/adjuvants/delivery for the next decade (CVADD): Heidelberg, Germany, 10–12 October 2007

Tumor-cell number and viability as quality and efficacy parameters of autologous virus-modified cancer vaccines in patients with breast or ovarian cancer

Polarization of human monocyte-derived dendritic cells to DC1 by in vitro stimulation with Newcastle Disease Virus

Immunization with virus-modified tumor cells

Generation of dendritic cells from human bone marrow mononuclear cells: advantages for clinical application in comparison to peripheral blood monocyte derived cells

Expression of RIG-I, IRF3, IFN-beta and IRF7 determines resistance or susceptibility of cells to infection by Newcastle Disease Virus

Newcastle disease virus-infected intact autologous tumor cell vaccine for adjuvant active specific immunotherapy of resected colorectal carcinoma

Bone marrow as a priming site for T-cell responses to blood-borne antigen

In situ analysis of tumor-specific CTL effector and memory responses elicited by tumor vaccination

Interaktionen zwischen Tumorantigen-reaktiven T-Zellen des Knochenmarks und Tumorzellen bei Patientinnen mit Mammakarzinom

Specific immune recognition of pancreatic carcinoma by patient-derived CD4 and CD8 T cells and its improvement by interferon-γ

Tumor selective replication of Newcastle disease virus: Association with defects of tumor cells in antiviral defence

Newcastle disease virus activates macrophages for anti-tumor activity

Suchergebnisse filtern